SlideShare uma empresa Scribd logo
1 de 57
Syeda Baseerat
•   Recognize the importance of diabetic
    retinopathy as a public health problem
•   Discuss diabetic retinopathy as a leading cause
    of blindness in developed countries
•   Identify the risk factors for diabetic retinopathy
•   Describe and distinguish between the stages of
    diabetic retinopathy
Diabetes Mellitus is a group of diseases characterized by high blood
glucose levels. Diabetes results from defects in the body's ability to
produce and/or use insulin.
• Type 1 diabetes is usually diagnosed in children and young
   adults, and was previously known as juvenile diabetes. In type 1
   diabetes, the body does not produce insulin. 5% of people with
   diabetes have this form of the disease.
• In Type 2 diabetes, either the body does not produce enough
   insulin or the cells ignore the insulin. This is the most common
   form of diabetes.
 Blindness
 Kidney  failure
 Myocardial infarction
 Stroke
 Hypertension
 dyslipidemia
 Anyone  with diabetes is at risk of diabetic
  retinopathy.
 Approximately 45% of diabetic have diabetic
  retinopathy.
 The severity of hyperglycemia is the key
  alterable risk factor associated with the
  development of diabetic retinopathy
Definition:
Progressive dysfunction of the retinal blood vessels
          caused by chronic hyperglycemia.
•   DR can be a complication of diabetes type
    1 or diabetes type 2.
•   Initially, DR is asymptomatic, if not
    treated though it can cause low vision and
    blindness.
 Diabetic retinopathy is responsible for 1.8
  million of the 37 million cases of blindness
  throughout the world .
 Diabetic retinopathy (DR) is also the
  leading cause of blindness
•   After 20 years of diabetes, nearly 99% of
    patients with type 1 diabetes and 60% with
    type 2 have some degree on diabetic
    retinopathy
•   33% of patients with diabetes have signs of
    diabetic retinopathy
•   High Blood Sugar
•   HTN
•   Hyperlipidemia
   Having difficulty with fine details (e.g. when reading or
    watching television)
   Having difficulty with outdoor travel
   Experiencing visual fluctuations from hour to hour or day
    to day
   Seeing images as rippled (e.g. straight lines appear bent)
   Experiencing blurred, hazy or double vision
   Losing some visual field
   Having difficulty seeing at night or in low light
   Being particularly sensitive to glare and light
   Having difficulty focusing.
 1. Mild Nonproliferative Retinopathy
 2. Moderate Nonproliferative Retinopathy
  3. Severe Nonproliferative Retinopathy
       4. Proliferative Retinopathy
Characteristics
            • Microaneurysms only
 Thishappens when the tiny blood vessels of
 the retina begin to swell.
Microaneurysms
Characteristics
                  • Microaneurysms
                   • Hard exudates
           •   Flamed shaped hemorrhage
Damage to the blood vessels growth.

     The blood vessels become blocked
Microaneurysm



Hard exudates




Flamed shaped
hemorrhage
Hard exudates




microaneurysm
Any of the following:
•    More than 20 intraretinal hemorrhages in each of four
     quadrants
•    Definite venous beading in two or more quadrants
•    Prominent Intraretinal Microvascular Abnormalities
     (IRMA) in one or more quadrants
•    And no signs of proliferative retinopathy
 -Blood supply is blocked causing the eye to
 signal the need for new blood vessels.
IRMA
Venous beading
Venous beading
Characteristics
• Neovascularization
• Vitreous hemorrhage
   The retina sends signals so new blood vessels are created.
    These blood vessels are abnormal and more likely to
    hemorrhage due to the thin walls of the vessel. The walls
    of these vessels are weak and soon begin to hemorrhage
Cotton-wool
                        spot




Neovascularization

Neovascularization
                        Hard exudate
                     Blot hemorrhage
At risk for serious vision loss
 Any combination of three of the following four
 findings
• Presence of vitreous or preretinal hemorrhage.
• Presence of new vessels (neovascularization, NV)
• Location of NV on or near the optic disc.
• Moderate to severe extent of new vessels.
•   Diabetic macular edema is the leading
    cause of legal blindness in diabetics.
•   Diabetic macular edema can be present
    at any stage of the disease, but is more
    common in patients with proliferative
    diabetic retinopathy.
 The  macula is responsible for central vision.
 Diabetic macular edema may be
  asymptomatic at first. As the edema moves
  in to the fovea (the center of the macula)
  the patient will notice blurry central vision.
  The ability to read and recognize faces will
  be compromised.

                                      Macula
                                      Fovea
Normal   Macular Edema
•   Thickening of the retina at or within 500
    µm of the center of the macula.
•   Hard exudates at or within 500 µm of the
    center of the macula, if associated with
    thickening of the adjacent retina.
•   Area of retinal thickening 1 disc area or
    larger, within 1 disc diameter of the
    center of the macula.
The best measure for prevention
of loss of vision from diabetic
retinopathy is strict glycemic
control
90 percent of diabetic eye disease can
be prevented simply by proper regular
   examinations, treatment and by
       controlling blood sugar.
Primary prevention
               Strict glycemic control
               Blood pressure control


Secondary prevention
               Annual eye exams




Tertiary prevention
              Retinal Laser
photocoagulation
              Vitrectomy
 Laser photocoagulation is a therapy for
  numerous retinal diseases.
 Photocoagulation uses light to coagulate
  tissue. When energy from a strong light source is
  absorbed by tissue and is converted into thermal
  energy, coagulation necrosis occurs with
  denaturation of cellular proteins as temperature
  rises above 65 degrees C
Indications:
 Laser Photocoagulation is recommended for
 eyes with:
• Clinical significant macular edema (CSME)
• High risk Proliferative diabetic
   retinopathy
• Ocular tumors
Laser therapy to seal leaking blood
vessels (focal laser)



Laser therapy to reduce retinal
oxygen demand (scatter laser)




Surgical removal of blood from the
eye (vitrectomy)
Vitrectomy is surgery to remove some or all of
  the vitreous humor from the eye. Anterior
  vitrectomy entails removing small portions of
  the vitreous from the front structures of the eye
Pars plana vitrectomy is a general term for a
  group of operations accomplished in the deeper
  part of the eye, all of which involve removing
  some or all of the vitreous—the eye's clear
  internal jelly.
Diabetic Retinopathy is
preventable through strict
glycemic control and annual
dilated eye exams by an
ophthalmologist.
diabetic retinopathy

Mais conteúdo relacionado

Mais procurados

Age related macular degeneration
Age  related  macular degenerationAge  related  macular degeneration
Age related macular degenerationikramdr01
 
Anatomy and physiology of cornea
Anatomy and physiology of corneaAnatomy and physiology of cornea
Anatomy and physiology of corneaSSSIHMS-PG
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive RetinopathyHossein Mirzaie
 
Vitreous hemorrhage
Vitreous hemorrhageVitreous hemorrhage
Vitreous hemorrhagepoojamdm
 
Optic neuropathy
Optic neuropathyOptic neuropathy
Optic neuropathyNiwar Ameen
 
Papilloedema presentation1
Papilloedema presentation1Papilloedema presentation1
Papilloedema presentation1shovon2026
 
Congenital Glaucoma
Congenital GlaucomaCongenital Glaucoma
Congenital GlaucomaSahil Thakur
 
Central retinal artery occlusion
Central retinal artery occlusionCentral retinal artery occlusion
Central retinal artery occlusionSSSIHMS-PG
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathyDevashree N
 
DIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASEDIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASEHossein Mirzaie
 
Hypermetropia ppt
Hypermetropia pptHypermetropia ppt
Hypermetropia pptavinas
 
Retinal diseases of eye
Retinal diseases of eyeRetinal diseases of eye
Retinal diseases of eyeSayed Sara
 
Ocular Manifestation of Diabetes Mellitus
Ocular Manifestation of Diabetes MellitusOcular Manifestation of Diabetes Mellitus
Ocular Manifestation of Diabetes MellitusJoobin Khadamy . MD
 
Central retinal vein occlusion CRVO
Central retinal vein occlusion CRVOCentral retinal vein occlusion CRVO
Central retinal vein occlusion CRVODr. Md. Suzon Islam
 
Microspherophakia
MicrospherophakiaMicrospherophakia
Microspherophakiaikramdr01
 

Mais procurados (20)

Age related macular degeneration
Age  related  macular degenerationAge  related  macular degeneration
Age related macular degeneration
 
DIABETES AND THE EYE
DIABETES AND THE EYE DIABETES AND THE EYE
DIABETES AND THE EYE
 
Anatomy and physiology of cornea
Anatomy and physiology of corneaAnatomy and physiology of cornea
Anatomy and physiology of cornea
 
Optic nerve and its disorders
Optic nerve and its disorders Optic nerve and its disorders
Optic nerve and its disorders
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive Retinopathy
 
Vitreous hemorrhage
Vitreous hemorrhageVitreous hemorrhage
Vitreous hemorrhage
 
Optic neuropathy
Optic neuropathyOptic neuropathy
Optic neuropathy
 
Papilloedema presentation1
Papilloedema presentation1Papilloedema presentation1
Papilloedema presentation1
 
Congenital Glaucoma
Congenital GlaucomaCongenital Glaucoma
Congenital Glaucoma
 
Central retinal artery occlusion
Central retinal artery occlusionCentral retinal artery occlusion
Central retinal artery occlusion
 
Aphakia
AphakiaAphakia
Aphakia
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
DIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASEDIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASE
 
Ophthalmic Manifestations of Systemic Disorders
Ophthalmic Manifestations of Systemic Disorders Ophthalmic Manifestations of Systemic Disorders
Ophthalmic Manifestations of Systemic Disorders
 
Keratoconus
KeratoconusKeratoconus
Keratoconus
 
Hypermetropia ppt
Hypermetropia pptHypermetropia ppt
Hypermetropia ppt
 
Retinal diseases of eye
Retinal diseases of eyeRetinal diseases of eye
Retinal diseases of eye
 
Ocular Manifestation of Diabetes Mellitus
Ocular Manifestation of Diabetes MellitusOcular Manifestation of Diabetes Mellitus
Ocular Manifestation of Diabetes Mellitus
 
Central retinal vein occlusion CRVO
Central retinal vein occlusion CRVOCentral retinal vein occlusion CRVO
Central retinal vein occlusion CRVO
 
Microspherophakia
MicrospherophakiaMicrospherophakia
Microspherophakia
 

Semelhante a diabetic retinopathy

diabetic_retinopathy.ppt
diabetic_retinopathy.pptdiabetic_retinopathy.ppt
diabetic_retinopathy.pptarsingh15
 
Diabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathyDiabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathyVineela Cherukuri
 
diabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptxdiabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptxHarshika Malik
 
diabetic_retinopathy.ppt
diabetic_retinopathy.pptdiabetic_retinopathy.ppt
diabetic_retinopathy.pptNajmulHassan27
 
DIABETIC RETINOPATHY
DIABETIC RETINOPATHYDIABETIC RETINOPATHY
DIABETIC RETINOPATHYnemat1994
 
Diabetic Macular Edema (Surgery presentation)
Diabetic Macular Edema (Surgery presentation)Diabetic Macular Edema (Surgery presentation)
Diabetic Macular Edema (Surgery presentation)Shabana2428
 
diabeticretinopathy-190329164844.pptx
diabeticretinopathy-190329164844.pptxdiabeticretinopathy-190329164844.pptx
diabeticretinopathy-190329164844.pptxsainiboyRicky
 
DIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxDIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxLydiahkawira1
 
DIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxDIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxLydiahkawira1
 
DR from physicians perspective.pptx
DR from physicians perspective.pptxDR from physicians perspective.pptx
DR from physicians perspective.pptxManmathKumardas1
 
DIABETIC RETINOPATHY.pptx
DIABETIC  RETINOPATHY.pptxDIABETIC  RETINOPATHY.pptx
DIABETIC RETINOPATHY.pptxdratulkranand
 
Non Proliferative Diabetic Retinopathy
Non Proliferative Diabetic RetinopathyNon Proliferative Diabetic Retinopathy
Non Proliferative Diabetic RetinopathyFerdous101531
 
DIABETIC RETINOPATHY-postgraduate teaching.pptx
DIABETIC RETINOPATHY-postgraduate teaching.pptxDIABETIC RETINOPATHY-postgraduate teaching.pptx
DIABETIC RETINOPATHY-postgraduate teaching.pptxBARNABASMUGABI
 

Semelhante a diabetic retinopathy (20)

Diabetes retinopathy
Diabetes retinopathyDiabetes retinopathy
Diabetes retinopathy
 
diabetic_retinopathy.ppt
diabetic_retinopathy.pptdiabetic_retinopathy.ppt
diabetic_retinopathy.ppt
 
Diabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathyDiabetic and hypertensive retinopathy
Diabetic and hypertensive retinopathy
 
diabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptxdiabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptx
 
diabetic_retinopathy.ppt
diabetic_retinopathy.pptdiabetic_retinopathy.ppt
diabetic_retinopathy.ppt
 
DIABETIC RETINOPATHY
DIABETIC RETINOPATHYDIABETIC RETINOPATHY
DIABETIC RETINOPATHY
 
Diabetic Macular Edema (Surgery presentation)
Diabetic Macular Edema (Surgery presentation)Diabetic Macular Edema (Surgery presentation)
Diabetic Macular Edema (Surgery presentation)
 
diabeticretinopathy-190329164844.pptx
diabeticretinopathy-190329164844.pptxdiabeticretinopathy-190329164844.pptx
diabeticretinopathy-190329164844.pptx
 
DIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxDIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptx
 
DIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxDIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptx
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Diabetic Retinopathy
Diabetic RetinopathyDiabetic Retinopathy
Diabetic Retinopathy
 
Diabetic macular edema
Diabetic macular edemaDiabetic macular edema
Diabetic macular edema
 
46191.pptx
46191.pptx46191.pptx
46191.pptx
 
DR from physicians perspective.pptx
DR from physicians perspective.pptxDR from physicians perspective.pptx
DR from physicians perspective.pptx
 
DIABETIC RETINOPATHY.pptx
DIABETIC  RETINOPATHY.pptxDIABETIC  RETINOPATHY.pptx
DIABETIC RETINOPATHY.pptx
 
Non Proliferative Diabetic Retinopathy
Non Proliferative Diabetic RetinopathyNon Proliferative Diabetic Retinopathy
Non Proliferative Diabetic Retinopathy
 
DIABETIC RETINOPATHY-postgraduate teaching.pptx
DIABETIC RETINOPATHY-postgraduate teaching.pptxDIABETIC RETINOPATHY-postgraduate teaching.pptx
DIABETIC RETINOPATHY-postgraduate teaching.pptx
 
Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)
Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)
Ophthalmology 5th year, 6th lecture (Dr. Bakhtyar)
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 

Último

Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...ZurliaSoop
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxcallscotland1987
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Association for Project Management
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 

Último (20)

Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 

diabetic retinopathy

  • 2. Recognize the importance of diabetic retinopathy as a public health problem • Discuss diabetic retinopathy as a leading cause of blindness in developed countries • Identify the risk factors for diabetic retinopathy • Describe and distinguish between the stages of diabetic retinopathy
  • 3. Diabetes Mellitus is a group of diseases characterized by high blood glucose levels. Diabetes results from defects in the body's ability to produce and/or use insulin. • Type 1 diabetes is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. In type 1 diabetes, the body does not produce insulin. 5% of people with diabetes have this form of the disease. • In Type 2 diabetes, either the body does not produce enough insulin or the cells ignore the insulin. This is the most common form of diabetes.
  • 4.  Blindness  Kidney failure  Myocardial infarction  Stroke  Hypertension  dyslipidemia
  • 5.  Anyone with diabetes is at risk of diabetic retinopathy.  Approximately 45% of diabetic have diabetic retinopathy.  The severity of hyperglycemia is the key alterable risk factor associated with the development of diabetic retinopathy
  • 6.
  • 7. Definition: Progressive dysfunction of the retinal blood vessels caused by chronic hyperglycemia.
  • 8. DR can be a complication of diabetes type 1 or diabetes type 2. • Initially, DR is asymptomatic, if not treated though it can cause low vision and blindness.
  • 9.  Diabetic retinopathy is responsible for 1.8 million of the 37 million cases of blindness throughout the world .  Diabetic retinopathy (DR) is also the leading cause of blindness
  • 10. After 20 years of diabetes, nearly 99% of patients with type 1 diabetes and 60% with type 2 have some degree on diabetic retinopathy • 33% of patients with diabetes have signs of diabetic retinopathy
  • 11.
  • 12.
  • 13. High Blood Sugar • HTN • Hyperlipidemia
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. Having difficulty with fine details (e.g. when reading or watching television)  Having difficulty with outdoor travel  Experiencing visual fluctuations from hour to hour or day to day  Seeing images as rippled (e.g. straight lines appear bent)  Experiencing blurred, hazy or double vision  Losing some visual field  Having difficulty seeing at night or in low light  Being particularly sensitive to glare and light  Having difficulty focusing.
  • 22.
  • 23.  1. Mild Nonproliferative Retinopathy  2. Moderate Nonproliferative Retinopathy  3. Severe Nonproliferative Retinopathy  4. Proliferative Retinopathy
  • 24. Characteristics • Microaneurysms only
  • 25.  Thishappens when the tiny blood vessels of the retina begin to swell.
  • 26.
  • 28. Characteristics • Microaneurysms • Hard exudates • Flamed shaped hemorrhage
  • 29. Damage to the blood vessels growth. The blood vessels become blocked
  • 32. Any of the following: • More than 20 intraretinal hemorrhages in each of four quadrants • Definite venous beading in two or more quadrants • Prominent Intraretinal Microvascular Abnormalities (IRMA) in one or more quadrants • And no signs of proliferative retinopathy
  • 33.  -Blood supply is blocked causing the eye to signal the need for new blood vessels.
  • 34. IRMA
  • 38. The retina sends signals so new blood vessels are created. These blood vessels are abnormal and more likely to hemorrhage due to the thin walls of the vessel. The walls of these vessels are weak and soon begin to hemorrhage
  • 39. Cotton-wool spot Neovascularization Neovascularization Hard exudate Blot hemorrhage
  • 40. At risk for serious vision loss Any combination of three of the following four findings • Presence of vitreous or preretinal hemorrhage. • Presence of new vessels (neovascularization, NV) • Location of NV on or near the optic disc. • Moderate to severe extent of new vessels.
  • 41. Diabetic macular edema is the leading cause of legal blindness in diabetics. • Diabetic macular edema can be present at any stage of the disease, but is more common in patients with proliferative diabetic retinopathy.
  • 42.
  • 43.  The macula is responsible for central vision.  Diabetic macular edema may be asymptomatic at first. As the edema moves in to the fovea (the center of the macula) the patient will notice blurry central vision. The ability to read and recognize faces will be compromised. Macula Fovea
  • 44. Normal Macular Edema
  • 45. Thickening of the retina at or within 500 µm of the center of the macula. • Hard exudates at or within 500 µm of the center of the macula, if associated with thickening of the adjacent retina. • Area of retinal thickening 1 disc area or larger, within 1 disc diameter of the center of the macula.
  • 46.
  • 47. The best measure for prevention of loss of vision from diabetic retinopathy is strict glycemic control
  • 48. 90 percent of diabetic eye disease can be prevented simply by proper regular examinations, treatment and by controlling blood sugar.
  • 49. Primary prevention Strict glycemic control Blood pressure control Secondary prevention Annual eye exams Tertiary prevention Retinal Laser photocoagulation Vitrectomy
  • 50.  Laser photocoagulation is a therapy for numerous retinal diseases.  Photocoagulation uses light to coagulate tissue. When energy from a strong light source is absorbed by tissue and is converted into thermal energy, coagulation necrosis occurs with denaturation of cellular proteins as temperature rises above 65 degrees C
  • 51. Indications: Laser Photocoagulation is recommended for eyes with: • Clinical significant macular edema (CSME) • High risk Proliferative diabetic retinopathy • Ocular tumors
  • 52.
  • 53. Laser therapy to seal leaking blood vessels (focal laser) Laser therapy to reduce retinal oxygen demand (scatter laser) Surgical removal of blood from the eye (vitrectomy)
  • 54. Vitrectomy is surgery to remove some or all of the vitreous humor from the eye. Anterior vitrectomy entails removing small portions of the vitreous from the front structures of the eye Pars plana vitrectomy is a general term for a group of operations accomplished in the deeper part of the eye, all of which involve removing some or all of the vitreous—the eye's clear internal jelly.
  • 55.
  • 56. Diabetic Retinopathy is preventable through strict glycemic control and annual dilated eye exams by an ophthalmologist.

Notas do Editor

  1. http://www.diabetes.org/diabetes-basics/?loc=GlobalNavDB
  2. http://www.mdconsult.com/das/book/pdf/282715756-3/978-0-323-04332-8/4-u1.0-B978-0-323-04332-8..00092-5..DOCPDF.pdf?isbn=978-0-323-04332-8&eid=4-u1.0-B978-0-323-04332-8..00092-5..DOCPDF
  3. Ophthalmology Myron Handoff MD and Jay S. Duke Basic and Clinical Science Course, Section 12: Retina and Vitreous AAOhttp://www.aao.org/eyecare/news/upload/Eye-Health-Fact-Sheet.pdf -
  4. http://www.aao.org/newsroom/release/20091030.cfm